Clinical Trials Browser

INDUSTRY × Ovarian Neoplasms × Blood Specimen Collection × Clear all

Ovarian Neoplasms

NCT02785731 2018-11-09

Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.

Completed

204 enrolled

Gynecologic

Ovarian Neoplasms

NCT02016833 2015-04-30

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

Completed

15 enrolled

GynecologicMyeloidOther hematologic neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Leukemia, Ovarian Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT00436189 2008-04-30

Assess Cancer in Ovarian Tumors With Biomarkers.

Phase NA Completed

1,000 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms, Arachnodactyly

Clinical Trials

EMBER

Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

Assess Cancer in Ovarian Tumors With Biomarkers.